Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial (Q59809065)
Jump to navigation
Jump to search
scientific article published on 09 January 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial |
scientific article published on 09 January 2009 |
Statements
Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: results of a Phase 2, randomized, double-blind placebo-controlled trial (English)
Shigella dysenteriae
1 reference
Christine Sadorge
Nathalie Jolly
Béatrice Poirier
Stéphane Béchet
Diane van der Vliet
Valérie Seffer
Nicola Fenner
Kelly Dowling
Raphaela Giemza
Julie Johnson
Anna Ndiaye
Muriel Vray
Philippe Sansonetti
Philippe Morand
Marie-Lise Gougeon
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference